// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

14,506
Stories Indexed
Live
Feed Status
6
Data Sources
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
REGULATORY · 14,506 results Live
Regulatory KEY Jun 3 — 0.00

KeyCorp auditor consents to incorporation of financial statements in registration statements.

Ernst & Young LLP consented to the incorporation by reference of its audit report for KeyCorp's consolidated financial statements across multiple Form S-3 and S-8 registration stat…

Regulatory S3D Jun 3 — 0.00

Sphere 3D creates Series I Preferred Shares with unlimited authorization

Sphere 3D's board adopted resolutions to establish a new series of unlimited Series I Preferred Shares, with rights and preferences to be determined. The filing relates to the comp…

Regulatory SLM Jun 3 — 0.00

SLM Student Loan Trust 2003-7 discloses April 30, 2026 loan pool composition

The filing provides detailed characteristics and composition of the student loan trust portfolio as of April 30, 2026, including loan selection criteria and borrower statistics. Th…

Regulatory SLM Jun 3 — 0.00

SLM Student Loan Trust 2003-1 discloses April 30, 2026 portfolio statistics

The trust released detailed characteristics of its student loan pool as of April 30, 2026, including $1.3M in accrued interest and portfolio composition metrics. The disclosure pro…

Regulatory OSUR Jun 3 — 0.00

OraSure Technologies amends certificate of incorporation to change board structure.

OraSure Technologies filed a certificate of amendment modifying its board of directors structure, transitioning from a staggered three-class system to single-year terms beginning i…

Regulatory STEM Jun 3 — 0.00

STEM amends 2024 equity incentive plan effective June 3, 2026

STEM, Inc. filed a second amended and restated 2024 equity incentive plan to govern employee, director and consultant stock awards including options, RSUs and restricted stock. The…

Regulatory ADCT Jun 3 ▲ +0.65

ADC Therapeutics ZYNLONTA plus rituximab met primary endpoint in Phase 3 LOTIS-5 trial

ADC Therapeutics announced positive topline data from LOTIS-5 Phase 3 trial showing ZYNLONTA combined with rituximab achieved statistical significance on progression-free survival …

Regulatory REED Jun 3 ▼ -0.80

Reed's receives NYSE deficiency notice for low stockholders' equity

Reed's Inc. received a notice from NYSE American on May 29, 2026, that the company is below compliance with listing standards due to stockholders' equity of $2.7 million and net lo…

Regulatory FONAR Jun 3 — 0.00

FONAR Corp amends certificate of incorporation with Delaware filing

FONAR Corporation filed an amended and restated certificate of incorporation updating its Delaware corporate structure and governance provisions. The filing establishes standard di…

Regulatory PNTL Jun 3 — -0.10

Pineapple Financial changes certifying accountant to MNP LLP.

Pineapple Financial Inc. has changed its certifying accountant, with MNP LLP consenting to the change filed in an 8-K on June 3, 2026. Auditor changes can signal accounting concern…

Regulatory INMD Jun 3 — 0.00

InspireMD amends certificate to increase authorized shares to 255 million

InspireMD increased its authorized shares to 255 million, consisting of 250 million common shares and 5 million preferred shares. The amendment was approved by stockholders and pro…

Regulatory TECHLOTT Jun 3 — 0.00

Techlott Inc. files amended certificate of incorporation as Exhibit 3.1

Techlott Inc. submitted an amended certificate of incorporation in SEC filing. The filing indicates a corporate governance or structural update to the company's charter documents.

Regulatory KKR Jun 3 — 0.00

KKR FS Income Trust amends senior secured revolving credit agreement

KKR FS Income Trust executed a third amendment to its senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation as administrative agent, dated May 28, 2026.…

Regulatory EG Jun 3 — 0.00

KPMG consents to incorporation of audit report in Everest Group registration statements.

KPMG LLP provided consent for incorporating its February 26, 2026 audit report into Everest Group's S-3 and S-8 registration statements, with a June 3, 2026 date for segment report…

Regulatory EZRA Jun 3 ▲ +0.65

Reliance Global Group regains Nasdaq compliance after stock price recovery

Reliance Global Group's common stock regained compliance with Nasdaq's minimum $1.00 bid price requirement after trading at or above that level for 10 consecutive business days. Th…

Regulatory SEII Jun 3 — 0.00

LAO Professionals confirms agreement with auditor change disclosure in 8-K filing

Sharing Economy International Inc. filed an 8-K on May 28, 2026 disclosing an auditor change, with LAO Professionals confirming the accuracy of related statements. This confirms a …

Regulatory REX Jun 3 — 0.00

REX American Resources amends certificate to authorize 90M shares

REX American Resources Corporation amended its certificate of incorporation to set total authorized shares at 90 million with $0.01 par value. The change allows the company flexibi…

Regulatory SBEV Jun 3 ▼ -0.25

Splash Beverage submits NYSE compliance plan; Medterra CBD deal expires

Splash Beverage submitted a compliance plan to NYSE American on May 28, 2026 to address stockholders' equity concerns, with potential cure period through January 29, 2027. The comp…

Regulatory CRDF Jun 3 ▲ +0.50

Cardiff Oncology announces interim Phase 2 CRDF-004 trial results for onvansertib

Cardiff Oncology released interim results from its randomized Phase 2 CRDF-004 trial evaluating onvansertib combined with standard chemotherapy and bevacizumab for first-line RAS-m…

Regulatory RNAZ Jun 3 ▲ +0.85

TransCode completes Phase 1a trial for TTX-MC138 with no dose-limiting toxicities

TransCode Therapeutics announced positive Phase 1a results for its lead candidate TTX-MC138, showing safety, tolerability, and disease stabilization in metastatic cancer patients a…